Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2600120365Phase 4Recruiting
Phase 4, randomised trial in Cerebral Hypoxia, post-operative cognitive decline (POCD) and None comparing Ciprofol arm with Propofol arm (2 arms). Primary endpoint: AUC of rSO2 deviation from baseline during induction to thoracotomy. Started Mar 2026; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2600120365.